Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Pedro J, Beltran"'
Autor:
Jinghui Zhan, Petia Mitchell, Juan Estrada, Jonathan Werner, Jason DeVoss, Pedro J Beltran, Jing Qing, Keegan S Cooke
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
Background Checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) have demonstrated clinical efficacy in advanced melanoma, but only a sub
Externí odkaz:
https://doaj.org/article/36defbad0cc24b22bfdec87dbe9052f1
Autor:
Kai Mao, Gabriela Farias Quipildor, Tahmineh Tabrizian, Ardijana Novaj, Fangxia Guan, Ryan O. Walters, Fabien Delahaye, Gene B. Hubbard, Yuji Ikeno, Keisuke Ejima, Peng Li, David B. Allison, Hossein Salimi-Moosavi, Pedro J. Beltran, Pinchas Cohen, Nir Barzilai, Derek M. Huffman
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Reduced IGF-1 signaling increases longevity in many organisms. Here, Mao et al. show that administration of an anti-IGF-1R antibody is well tolerated and delays aging in female mice; importantly, late-life targeting is sufficient to achieve the benef
Externí odkaz:
https://doaj.org/article/6c2da7569db9463080f4475bda1b2e80
Prostate cancer is the most commonly diagnosed malignancy in men. While tumors initially respond to androgen-deprivation therapy, the standard care for advanced or metastatic disease, tumors eventually recur as castration-resistant prostate cancer (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ebf04a5351a3da4e068612c94f31ff
https://doi.org/10.1158/1535-7163.c.6535687
https://doi.org/10.1158/1535-7163.c.6535687
PDF file - 106K, Assessment of full length AR and splice variant AR3 (AR-V7) transcript levels in VCaP xenografts treated with combined androgen-deprivation therapy (castration) and ganitumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7ed376063e8b116f27862402ff58a6
https://doi.org/10.1158/1535-7163.22497691.v1
https://doi.org/10.1158/1535-7163.22497691.v1
PDF file - 151K, Assessment of phospho-AKT and total AKT in VCaP xenografts treated with combined androgen-deprivation therapy (castration) and ganitumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92f3e14b2a19dfe7b334f074e29a812e
https://doi.org/10.1158/1535-7163.22497694.v1
https://doi.org/10.1158/1535-7163.22497694.v1
PDF file - 151K, Evaluation of AR and ARΔLBD in androgen-dependent VCaP xenografts, castration-resistant VCaP xenografts, and castration-resistant 22Rv1 xenografts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee46832127bf8a62561644c9784ce1b
https://doi.org/10.1158/1535-7163.22497697
https://doi.org/10.1158/1535-7163.22497697
PDF file - 41K, Table of weights of mice from VCaP and 22Rv1 xenograft studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd31acd7d7405f63a2287c27ac4e49a
https://doi.org/10.1158/1535-7163.22497682.v1
https://doi.org/10.1158/1535-7163.22497682.v1
PDF file - 65K, Schematic of IGF-1R Signaling Pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb49a5b3f9e0ec74467f4fb10a38373
https://doi.org/10.1158/1535-7163.22497700
https://doi.org/10.1158/1535-7163.22497700